Phosphine,tris[3,5-bis(trifluoromethyl)phenyl]-
Product Information
Molecular Formula
C24H9 F18 P
Molecular Weight
670.27
Description
Phosphine,tris[3,5-bis(trifluoromethyl)phenyl]- is a vital compound in the biomedical industry used for various purposes. It acts as a catalyst in organic synthesis reactions and is employed in the development of pharmaceutical drugs targeting specific diseases. This compound exhibits exceptional stability and reactivity, making it an essential tool in drug discovery and synthesis processes. Its unique properties make it suitable for treating various diseases and developing novel therapeutic interventions.
Synonyms
TRI[3,5-DI(TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[3,5-BIS(TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[3,5-DI(TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[BIS(3,5-TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[3,5-BIS(TRIFLUOROMETHYL)PHENYL]PHOSPHINE 97%; Tris[3,5-bis(trifluorom
IUPAC Name
tris[3,5-bis(trifluoromethyl)phenyl]phosphane
SMILES
C1=C(C=C(C=C1C(F)(F)F)P(C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(F)(F)F
InChI
InChI=1S/C24H9F18P/c25-19(26,27)10-1-11(20(28,29)30)5-16(4-10)43(17-6-12(21(31,32)33)2-13(7-17)22(34,35)36)18-8-14(23(37,38)39)3-15(9-18)24(40,41)42/h1-9H
InChI Key
ITJHLZVYLDBFOJ-UHFFFAOYSA-N
Boiling Point
128-130°C 0,5mm
Melting Point
95°C
Flash Point
Not applicable
Purity
95%
Appearance
yellow-brown
Storage
Keep under Nitrogen
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
XLogP3
9.9
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
18
Rotatable Bond Count
3
Exact Mass
670.0154442 g/mol
Monoisotopic Mass
670.0154442 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
43
Formal Charge
0
Complexity
741
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-112062772-A | Organic compound, organic photoelectric element using same and application | 2020-09-10 |
| CN-112142752-A | Organic compound, organic photoelectric element using same and application | 2020-09-10 |
| CN-112062774-A | Organic compound and organic electroluminescent device using same | 2020-09-09 |
| CN-112062753-A | Organic compound, organic photoelectric element using same and application | 2020-09-09 |
| CN-112079844-A | Organic compound, organic photoelectric element using same and application | 2020-09-09 |
| CN-114149422-A | Condensed ring compound and organic electronic device | 2020-09-08 |
| WO-2022003040-A1 | Process for treating keratin fibers using particular amino acids in high concentration | 2020-06-30 |
| JP-2021126617-A | Carbon dioxide reduction catalyst | 2020-02-13 |
| JP-2021109157-A | Carbon compound reduction catalyst | 2020-01-14 |
| JP-2021053622-A | Carbon compound reduction catalyst | 2019-09-24 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 21557356 | 2011-06-14 | Synthesis, characterisation and application of iridium(III) photosensitisers for catalytic water reduction | Chemistry (Weinheim an der Bergstrasse, Germany) |
| 20024326 | 2010-01-07 | Ortho-C-H borylation of benzoate esters with bis(pinacolato)diboron catalyzed by iridium-phosphine complexes | Chemical communications (Cambridge, England) |
| 16129706 | 2005-09-05 | Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection | The Journal of experimental medicine |
| 16161315 | 2005-01-01 | [Regulation of glycemia, just where and when in the aged?] | Journees annuelles de diabetologie de l'Hotel-Dieu |
